...BRCA2 mutations, respectively. No deaths from breast cancer were recorded. Overall survival did not differ statistically...
...BRCA2 have raised the possibility of clinical genetic testing for breast cancer susceptibility. This study examined deci...
...BRCA2 (6174delT) mutations. We detected the APC I1307K mutation in 7% (11 of 158) of the Ashkenazi Jewish families and i...
...BRCA2 (ref. 15).
...BRCA2-Region): 28% both, D16S539 (16q22-24, E-Cadherin-Region): 35%, D17S5 (17p13.3): 17%, TP53 (17p13.1): 32% D17S250 (...
...BRCA2 (n=16), Lynch Syndrome (n=6), and CHEK2 (n = 4) known pathogenic germline variants. The median age and PSA were 58...
...BRCA2/TP53/TERT and their interplay between the related gene networks in BC initiation, progression and development of r...
...BRCA2, PALB2, CHEK2, and ATM through a standardized letter. Subsequently, women with normal test results were informed t...
...BRCA2 (BRCA) mutations in Korean patients with epithelial ovarian cancer (EOC). Two-hundred and ninety-eight Korean wome...
...BRCA2 mutation or in the homologous recombination deficiency (HRD)-test positive subgroup. These four well-conducted stu...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
